Retatrutide is a cutting-edge multi-receptor peptide agonist targeting GLP-1, GIP, and glucagon receptors. It exhibits remarkable efficacy in glycemic control and weight management, making it a promising ingredient for pharmaceutical R&D and advanced health products. Our high-purity Retatrutide undergoes strict quality control to ensure stable bioactivity and consistent performance.